Hamilton Beach Brands Holding Company, together with its subsidiaries, designs, markets, and distributes small electric household and specialty housewares appliances in the United States and internationally. It offers air fryers, blenders, coffee makers, food processors, indoor electric grills, irons, juicers, mixers, slow cookers, toasters, and toaster ovens. The company also provides consumer products under the Hamilton Beach and Proctor Silex brands; products under the Hamilton Beach Professional in the premium market; farm-to-table and field-to-table food processing equipment under the Weston brand; countertop appliances under the Wolf Gourmet brand; garment care products under the CHI brand; cocktail delivery system under the Bartesian brand; air purifiers under the Clorox and TrueAir brands; and water filtration systems under the Brita brand. In addition, it offers injection care management system under the Hamilton Beach Health brand; and commercial products under the Hamilton Beach Commercial and the Proctor Silex Commercial brands, as well as supplies private label products. The company sells its products through a network of mass merchandisers, e-commerce retailers, national department stores, variety store and drug store chains, specialty home retailers, distributors, restaurants, fast food chains, bars, hotels, and other retail outlets. Hamilton Beach Brands Holding Company was founded in 1904 and is headquartered in Glen Allen, Virginia.

Hamilton Beach Brands Holding Company

Thursday, May 29, 2025
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), AbbVie Inc. (ABBV) and Intuitive Surgical, Inc. (ISRG), as well as two micro-cap stocks Hamilton Beach Brands Holding Co. (HBB) and AXIL Brands, Inc. (AXIL). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Markets Stay Green After Tariff Ruling, Jobless Claims, Q1 GDP
Today's Featured Research Reports
Shares of Berkshire Hathaway have gained +10.8% over the year-to-date period against the Zacks Insurance - Property and Casualty industry’s gain of +16.1%. The company is one of the largest property and casualty insurance companies, with numerous diverse business activities. A strong cash position supports earnings-accretive bolt-on buyouts and is indicative of its financial flexibility.
Continued insurance business growth fuels an increase in float, drives earnings and generates maximum return on equity. The non-insurance businesses have also been doing well in the last few years. The insurer has also started increasing its investment in Japan. A sturdy capital level provides further impetus.
However, exposure to cat loss induces earnings volatility and also affects underwriting results. Huge capital expenditure remains a headwind. Also, it remains to be seen how the behemoth fares when Greg Abel succeeds Warren Buffett as CEO of Berkshire.
(You can read the full research report on Berkshire Hathaway here >>>)
AbbVie’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+6.1% vs. -4.2%). The company beats first-quarter estimates for both earnings and sales. AbbVie has successfully navigated Humira's loss of exclusivity (LOE) by launching two other successful new immunology medicines, Skyrizi and Rinvoq, which are performing extremely well, bolstered by approvals in new indications and should support top-line growth in the next few years.
AbbVie has several early/mid-stage candidates that have the potential to drive long-term growth. It expects to return to robust revenue growth in 2025, which is just the second year following the U.S. Humira LOE.
However, the company faces several near-term headwinds like Humira LOE impact, increasing competitive pressure on Imbruvica and slowing sales of its aesthetics franchise.
(You can read the full research report on AbbVie here >>>)
Shares of Intuitive Surgical have outperformed the Zacks Medical - Instruments industry over the year-to-date period (+6.9% vs. -9.2%). The company ended the first quarter on a strong note, beating estimates on both counts. Revenues are likely to be driven by continued improvement in the company’s da Vinci procedure volume, coupled with strong Ion procedure growth.
ISRG topline is also likely to aided by rising pricing of procedures to fight inflationary pressure. Launch of da Vinci SP in Europe and da Vinci 5 in U.S. market are bringing additional system placements. Opening new manufacturing facilities in Germany and Bulgaria should boost supply.
However, the continued slowdown in bariatric procedures is likely to continue in 2025 amid the rise of GLP-1 medications, hurting top-line growth. ISRG also expects a slow, gradual decline in Instruments & Accessories revenues per procedure over the next few years due to growth in benign procedures. Operating expenses are likely to be on the higher side in 2025.
(You can read the full research report on Intuitive Surgical here >>>)
Hamilton Beach Brands’ shares have outperformed the Zacks Household Appliances industry over the year-to-date period (+13.6% vs. -27.7%). This microcap company with market capitalization of $253.29 million posted strong first-quarter 2025 results, with gross margin up 120 bps to 24.6% despite tariff headwinds, driven by favorable mix and pricing. Operating profit rebounded to $2.3 million amid tight cost control.
Tariff mitigation, sourcing shifts, and foreign trade zone certification support margin resilience. The high-margin HealthBeacon unit is scaling rapidly, with 50%+ patient growth expected in 2025, aided by a new OptumHealth launch. Premium products like CHI and the upcoming Lotus line support share gains in the $4 billion U.S. appliance market.
E-commerce now accounts for 40% of U.S. sales, driven by a strong digital strategy. Geographic and channel diversification, including growth in Mexico and a new Sunkist partnership, enhances stability. Solid liquidity and disciplined capital allocation reinforce long-term growth prospects.
(You can read the full research report on Hamilton Beach Brands here >>>)
Shares of AXIL Brands have outperformed the Zacks Consumer Products - Staples industry over the year-to-date period (+60.4% vs. +3.2%). This microcap company with market capitalization of $41.03 million offers a compelling growth narrative driven by strong direct-to-consumer momentum, supported by enhanced e-commerce, data-driven marketing, and favorable Cyber Monday timing.
Gross margins remained robust at 71.7% in the third quarter of fiscal 2025 due to operational efficiency and product mix, with adjusted EBITDA margin expanding to 12.9%. Improved liquidity ($4.77 million in cash) and positive operating cash flow ($1.7 million for the first nine months of fiscal 2025) enhance financial flexibility. Strategic United States supply chain shifts bolster resilience, while global direct-to-consumer-led expansion reduces domestic dependency.
However, risks persist: weak inventory turnover, vendor and receivables concentration, elevated selling, general, and administrative expenses, and uncertain execution of domestic manufacturing could pressure margins and limit scalability if growth lags.
(You can read the full research report on AXIL Brands here >>>)
Other noteworthy reports we are featuring today include Howmet Aerospace Inc. (HWM), HEICO Corp. (HEI) and Warner Bros. Discovery, Inc. (WBD).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Solid Insurance Business Aid Berkshire (BRK.B), Cat Loss Ail
AbbVie's (ABBV) Skyrizi, Rinvoq Key to Top-Line Growth
Intuitive Surgical's (ISRG) da Vinci System Helps Offset Risks
Featured Reports
Acquisitions to Aid Heico (HEI), Shortage of Parts Woes
Per the Zacks analyst, disciplined acquisition strategy has been driving Heico's overall performance. However, shortage of parts supply might adversely impact the company's results of operations
Warner Bros. Discovery (WBD) Rides on Strong DTC Business
Per the Zacks analyst, Warner Bros. Discovery's streaming service Max is growing rapidly, targeting 150 million subscribers by 2026.
Healthy Demand Aids Essex Property (ESS) Amid High Supply
Per the Zacks Analyst, Essex Property is to gain from a sturdy property base in the West Coast market with favorable demand drivers. Yet, high supply of rental units restrict rent growth momentum.
Light & Wonder (LNW) Rides on Strong Demand, AI Integration
Per the Zacks analyst, growing demand for COSMIC UPRIGHT and HORIZON cabinets will likely drive Light & Wonder's top line. A strong emphasis on AI tools and process development is a positive.
Shake Shack (SHAK) Banks On Menu Innovation, Macro Woes Ail
Per the Zacks analyst, Shake Shack's focus on menu innovation, unit expansion and licensed business segment bodes well. Yet, weather challenges and an uncertain macro environment are concerns.
Strong AI Growth and Partnerships Aid Box (BOX) Prospects
Per the Zacks analyst, Box is benefiting from strong demand for Box AI, increased adoption of its Enterprise Advanced suite, and AI partnerships.
RPC's (RES) Diverse Oilfield Services Drives Stable Revenues
RPC generates stable revenues from diverse services. However, weak demand amid rising price competition and tariff risks concerns the Zacks analyst.
New Upgrades
Strength in Commercial Aerospace Market Drives Howmet (HWM)
Per the Zacks analyst, Howmet Aerospace is witnessing solid momentum in the commercial aerospace market, fueled by robust demand for engine spares. Its sound liquidity position adds to its strength.
Golar LNG (GLNG) Benefits From Dividends & Share Buybacks
The Zacks analyst likes the shareholder-friendly measures adopted by Golar LNG (GLNG). Such efforts boost investor confidence and the company's bottom line.
Strong Demand & Nissens Buyout Aid Standard Motor (SMP)
Per the Zacks analyst, Standard Motor is expected to gain from sustained demand for automotive parts. The acquisition of Nissens is also expected to boost top-line growth.
New Downgrades
Corcept's (CORT) Korlym Dependence for Sales Raises Concerns
Per the Zacks analyst, Corcept's sole dependence on Cushing's syndrome drug, Korlym, for revenues is concerning. Recent pipeline setbacks weigh heavily on the stock.
Weaker Demand & High Capital Requirement Ail PACCAR (PCAR)
Per the Zacks analyst, PACCAR faces demand headwinds as the 2025 outlook for North American and South American markets weakens. Rising capital requirement also raises concerns.
Soft Demand in China Drags Skechers' (SKX) Sales
Per the Zacks analyst, Skechers' 16% sales decline in China during the first quarter signals macro pressures and soft demand, raising near-term concerns for the brand's international growth strategy.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
Berkshire Hathaway Inc. (BRK.B) : Free Stock Analysis Report
Warner Bros. Discovery, Inc. (WBD) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
Heico Corporation (HEI) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
Howmet Aerospace Inc. (HWM) : Free Stock Analysis Report
AXIL Brands, Inc. (AXIL): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

Wednesday, April 2, 2025
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), Bristol-Myers Squibb Co. (BMY) and Chubb Ltd. (CB), as well as a micro-cap stock Hamilton Beach Brands Holding Co. (HBB). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Markets Down Again on "Liberation Day"
Today's Featured Research Reports
Shares of Exxon Mobil have gained +3.2% over the past year, against the Zacks Oil and Gas - Integrated - International industry’s gain of +5.5%. The company’s high-value assets in the Permian Basin and Guyana drive robust production growth, doubling upstream earnings since 2019. The Pioneer acquisition and Guyana ramp-up have enhanced profitability, while robust structural savings strengthen resilience.
With a lower exposure to debt capital, XOM supports steady cash flows, dividends, buybacks and investments in high-return projects. Expansion in low-carbon tech, including Baytown's hydrogen facility, positions it for future growth.
Yet refining margins are pressured due to global capacity increases, with refining profits softening. The refining margin pressure intensifies the reliance on upstream operations, which is vulnerable to fluctuating oil and gas prices. Commodity price volatility challenges profitability, especially as crude prices dipped in the fourth quarter.
(You can read the full research report on Exxon Mobil here >>>)
Bristol-Myers Squibb’s shares have outperformed the Zacks Medical - Biomedical and Genetics industry over the past year (+19.8% vs. -8.7%). The company’s newer drugs like Reblozyl, Breyanzi, Yervoy, Camzyos and Opdualag maintain momentum for the company. Label expansion of blockbuster oncology drug Opdivo should fuel growth. Growth in blockbuster drug Eliquis is another positive.
Nevertheless, the recent acquisitions of Mirati, Karuna and RayzeBio should strengthen and diversify its portfolio. Bristol Myers’ efforts to streamline operations should boost the bottom line. The company is encouraging efforts to boost top-line growth.
However, the outlook for 2025 is weak. Generic competition for Revlimid, Pomalyst, Sprycel and Abraxane is adversely impacting revenue growth. While the performance of new drugs is encouraging, they will take some time to make a significant contribution to the top line.
(You can read the full research report on Bristol-Myers Squibb here >>>)
Shares of Chubb have gained +19.8% over the past year against the Zacks Insurance - Property and Casualty industry’s gain of +25.1%. The company’s suite of compelling products as well as services, focus on capitalizing on the potential of middle-market businesses and investments in various strategic initiatives pave the way for long-term growth.
Several distribution agreements have expanded its network, boosting its market presence. An impressive inorganic growth story helps to achieve a higher long-term return on equity. Chubb boasts a strong capital position with sufficient cash generation capabilities that ensure steady payouts to investors.
Chubb expects the quarterly adjusted net investment income to have a run rate between $1.67 billion and $1.75 billion over the next six months. However, exposure to catastrophe loss induces underwriting volatility. Escalating expenses weigh on margin expansion.
(You can read the full research report on Chubb here >>>)
Hamilton Beach Brands’ shares have outperformed the Zacks Household Appliances industry over the year-to-date period (+18.7% vs. -17.7%). This microcap company with market capitalization of $268.41 million achieved a record gross margin of 26% in 2024, up 300 bps year over year, driven by lower costs, improved mix and pricing discipline.
Operating profit rose 23.1% to $43.2 million. A strong cash flow of $65.4 million enabled debt elimination, ending with a net cash position of $0.6 million. HBB expanded into high-margin healthcare with HealthBeacon, targeting more than 50% patient growth in 2025. Product innovation, including premium offerings and e-commerce expansion, is driving market share gains.
U.S. consumer sales rose 3.6%, with strong growth in Mexico and commercial blender placements. Proactive tariff mitigation and supply-chain diversification protect margins. The 2025 guidance includes mid-single-digit revenue growth, operating profit outpacing sales and $40-$50 million in free cash flow.
(You can read the full research report on Hamilton Beach Brands here >>>)
Other noteworthy reports we are featuring today include Barclays PLC (BCS), Freeport-McMoRan Inc. (FCX) and Waste Connections, Inc. (WCN).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
ExxonMobil's (XOM) Guyana & Permian Assets Aid Production
New Drugs Fuel Bristol Myers (BMY) Amid Generic Competition
Better Pricing, New Business Growth Drive Chubb Limited (CB)
Featured Reports
Exploration Progress, Debt Reduction to Aid Freeport (FCX)
Per the Zacks analyst, Freeport will gain from its progress in exploration activities to expand production capacity and efforts to deleverage its balance sheet amid headwinds from higher costs.n
Operating Prowess Aid Waste Connections (WCN), Liquidity Low
Per the Zacks analyst, Waste Connections' low-overhead, highly efficient operational structure allows it to expand into geographically contiguous markets. Low liquidity remains a concern.
Strength in Cash App and Square Ecosystem Aids Block (XYZ)
Per the Zacks analyst, Block is benefitting from strengthening Cash App engagement and Square ecosystem, which is contributing well to its gross payment volume.
Sun Life (SLF) Gains on Solid Asia Business Amid High Costs
Per the Zacks analyst, Sun Life is set for grow on solid Asia business that are expected to provide higher return and expanding global asset management business. However, high costs remain a concern.
Solid Growth Across Segments, AI Integration Aid HubSpot (HUBS)
Per the Zacks Analyst, HubSpot is set to benefit from solid user engagement across all segments. Management's strong focus on integrating AI capabilities across the product suites is a tailwind.
DICK'S Sporting's (DKS) Sturdy Comps Run to Propel Top-Line
Per the Zacks analyst, strong transactions and pricing have aided DICK'S Sporting's comps and top line. Growth stems from its omnichannel strategy, unique products, brand loyalty, and top-tier service
Bio-Techne (TECH) Banks on Growth Pillar, Macro Woes Worry
The Zacks analyst is impressed with Bio-Techne's ongoing traction in the GMP reagents business, a key part of its cell and gene therapy growth vertical. Yet, macroeconomic woes may hurt its profits.
New Upgrades
Restructuring, Strategic Buyouts to Support Barclays (BCS)
Per the Zacks analyst, restructuring efforts to simplify business and boost operating efficiency, Tesco's retail banking operation buyout and solid balance sheet will likely aid Barclays' financials.
RingCentral (RNG) Rides on Strong Portfolio, Partner Base
Per the Zacks analyst, RingCentral benefits from solid demand for its Unified Communications as a Service and contact center software-as-a-service solutions.
Rising Commercial and Defense Orders Aid Triumph Group (TGI)
Per the Zacks analyst, Triumph Group is likely to benefit from increasing orders from its diverse customer base including commercial airplane producers and various military organizations globally.
New Downgrades
Low Volumes to Weigh on Caterpillar's (CAT) Results
The Zacks analyst is concerned that the low volume trends in two of its major segments- Construction Industries and Resource Industries will continue to hurt Caterpillar's top-line performance.
Mondelez (MDLZ) Struggles With Cost Inflation, Pricing Helps
Per the Zacks analyst, Mondelez is struggling with soaring cocoa costs, currency headwinds, and margin pressure. However, strategic pricing actions help offset some inflationary challenges.
Weak Residential Construction Hurts Owens Corning (OC)
Per the Zacks analyst, Owens Corning business is being hurt by weak residential new construction and remodeling activities. Also, cost inflation surrounding the market is an added concern.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report
Exxon Mobil Corporation (XOM) : Free Stock Analysis Report
Barclays PLC (BCS) : Free Stock Analysis Report
Freeport-McMoRan Inc. (FCX) : Free Stock Analysis Report
Chubb Limited (CB) : Free Stock Analysis Report
Waste Connections, Inc. (WCN) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Research Reports for Exxon Mobil, Bristol-Myers Squibb & Chubb

For Immediate Release
Chicago, IL – March 17, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AbbVie Inc. ABBV, Lockheed Martin Corp. LMT, Dell Technologies Inc. DELL and Hamilton Beach Brands Holding Co. HBB.
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for AbbVie, Lockheed Martin and Dell
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc., Lockheed Martin Corp. and Dell Technologies Inc., as well as a micro-cap stock Hamilton Beach Brands Holding Co. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Market Futures in the Green... for Now
Today's Featured Research Reports
AbbVie’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+20.1% vs. +5.3%). The company has successfully navigated Humira's loss of exclusivity (LOE) by launching two other successful new immunology medicines, Skyrizi and Rinvoq, which are performing extremely well, bolstered by approvals in new indications and should support top-line growth in the next few years.
AbbVie has several early/mid-stage candidates that have the potential to drive long-term growth. It expects to return to robust revenue growth in 2025 following the Humira LOE. AbbVie has been on an acquisition spree lately in its core space of immunology.
However, the company faces several near-term headwinds like Humira’s biosimilar erosion, increasing competitive pressure on Imbruvica and slow market growth trend for Juvederm fillers in the United States and China.
(You can read the full research report on AbbVie here >>>)
Shares of Lockheed Martin have outperformed the Zacks Aerospace - Defense industry over the past year (+9.6% vs. -4.5%). The company remains the largest U.S. defense contractor with a steady order flow from its leveraged presence in the Army, Air Force, Navy and IT programs. The company’s products are also well-acclaimed in the international market.
The increased funding offered for its defense products by the U.S. government should boost its business. The F-35 combat jet program remains a major revenue contributor for Lockheed. The company holds a strong solvency position.
However, Lockheed is facing performance issues concerning some of its programs that may lead to notable losses. A shortage of skilled labor in the aerospace and defense industry may adversely impact Lockheed’s future operating results. The sanctions imposed by China on Lockheed might also affect its business.
(You can read the full research report on Lockheed Martin here >>>)
Dell’s shares have underperformed the Zacks Computer - Micro Computers industry over the past year (-9.7% vs. +20.8%). The company is suffering from a challenging macroeconomic environment. It suffers from stiff competition in the PC market from the likes of HP and Lenovo.
Nevertheless, Dell is benefiting from strong demand for AI servers driven by ongoing digital transformation and heightened interest in generative AI applications. Its PowerEdge XE9680L AI-optimized server is very much in demand. Strong enterprise demand for AI-optimized servers is aiding Dell. It is witnessing demand from a diversified customer base that includes the likes of higher education institutions, financial services, health care and life services and manufacturing.
An expanding partner base that includes the likes of NVIDIA, Microsoft, Meta Platforms and Imbue has been a major growth driver. Dell’s shareholder-friendly approach makes it an attractive investment.
(You can read the full research report on Dell here >>>)
Shares of Hamilton Beach have declined -7.2% over the past year against the Zacks Household Appliances industry’s decline of -8.3%. This microcap company with market capitalization of $268.27 million achieved a record gross margin of 26% in 2024, up 300 bps year over year, driven by lower costs, improved mix and pricing discipline. Operating profit rose 23.1% to $43.2 million.
A strong cash flow of $65.4 million enabled debt elimination, ending with a net cash position of $0.6 million. HBB expanded into high-margin healthcare with HealthBeacon, targeting more than 50% patient growth in 2025. Product innovation, including premium offerings and e-commerce expansion, is driving market share gains. U.S. consumer sales rose 3.6%, with strong growth in Mexico and commercial blender placements.
Proactive tariff mitigation and supply-chain diversification protect margins. The 2025 guidance includes mid-single-digit revenue growth, operating profit outpacing sales and $40-$50 million in free cash flow.
(You can read the full research report on Hamilton Beach here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
Dell Technologies Inc. (DELL) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands

Friday, March 14, 2025
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corp. (LMT) and Dell Technologies Inc. (DELL), as well as a micro-cap stock Hamilton Beach Brands Holding Co. (HBB). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Market Futures in the Green... for Now
Today's Featured Research Reports
AbbVie’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+20.1% vs. +5.3%). The company has successfully navigated Humira's loss of exclusivity (LOE) by launching two other successful new immunology medicines, Skyrizi and Rinvoq, which are performing extremely well, bolstered by approvals in new indications and should support top-line growth in the next few years.
AbbVie has several early/mid-stage candidates that have the potential to drive long-term growth. It expects to return to robust revenue growth in 2025 following the Humira LOE. AbbVie has been on an acquisition spree lately in its core space of immunology.
However, the company faces several near-term headwinds like Humira’s biosimilar erosion, increasing competitive pressure on Imbruvica and slow market growth trend for Juvederm fillers in the United States and China.
(You can read the full research report on AbbVie here >>>)
Shares of Lockheed Martin have outperformed the Zacks Aerospace - Defense industry over the past year (+9.6% vs. -4.5%). The company remains the largest U.S. defense contractor with a steady order flow from its leveraged presence in the Army, Air Force, Navy and IT programs. The company’s products are also well-acclaimed in the international market.
The increased funding offered for its defense products by the U.S. government should boost its business. The F-35 combat jet program remains a major revenue contributor for Lockheed. The company holds a strong solvency position.
However, Lockheed is facing performance issues concerning some of its programs that may lead to notable losses. A shortage of skilled labor in the aerospace and defense industry may adversely impact Lockheed’s future operating results. The sanctions imposed by China on Lockheed might also affect its business.
(You can read the full research report on Lockheed Martin here >>>)
Dell’s shares have underperformed the Zacks Computer - Micro Computers industry over the past year (-9.7% vs. +20.8%). The company is suffering from a challenging macroeconomic environment. It suffers from stiff competition in the PC market from the likes of HP and Lenovo.
Nevertheless, Dell is benefiting from strong demand for AI servers driven by ongoing digital transformation and heightened interest in generative AI applications. Its PowerEdge XE9680L AI-optimized server is very much in demand. Strong enterprise demand for AI-optimized servers is aiding Dell. It is witnessing demand from a diversified customer base that includes the likes of higher education institutions, financial services, health care and life services and manufacturing.
An expanding partner base that includes the likes of NVIDIA, Microsoft, Meta Platforms and Imbue has been a major growth driver. Dell’s shareholder-friendly approach makes it an attractive investment.
(You can read the full research report on Dell here >>>)
Shares of Hamilton Beach have declined -7.2% over the past year against the Zacks Household Appliances industry’s decline of -8.3%. This microcap company with market capitalization of $268.27 million achieved a record gross margin of 26% in 2024, up 300 bps year over year, driven by lower costs, improved mix and pricing discipline. Operating profit rose 23.1% to $43.2 million.
A strong cash flow of $65.4 million enabled debt elimination, ending with a net cash position of $0.6 million. HBB expanded into high-margin healthcare with HealthBeacon, targeting more than 50% patient growth in 2025. Product innovation, including premium offerings and e-commerce expansion, is driving market share gains. U.S. consumer sales rose 3.6%, with strong growth in Mexico and commercial blender placements.
Proactive tariff mitigation and supply-chain diversification protect margins. The 2025 guidance includes mid-single-digit revenue growth, operating profit outpacing sales and $40-$50 million in free cash flow.
(You can read the full research report on Hamilton Beach here >>>)
Other noteworthy reports we are featuring today include Agnico Eagle Mines Limited (AEM), Hess Corporation (HES) and Summit Therapeutics Inc. (SMMT).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
AbbVie's (ABBV) Skyrizi, Rinvoq Key to Top-Line Growth
Defense Orders Drive Lockheed Martin (LMT), Amid Labor Shortage
Solid Demand for AI Servers Aids Dell Technologies (DELL)
Featured Reports
Growth Projects, Kirkland Buyout Aid Agnico Eagle (AEM)
Per the Zacks analyst, the company will benefit from investment in growth projects to expand output and its acquisition of Kirkland Gold amid headwinds from higher costs.
Haemonetics (HAE) Gains Ground on Growing Plasma Business
Per the Zacks analyst, high end-market demand for biopharmaceuticals should continue driving Haemonetics' plasma unit growth. The ongoing enhancement in the NexSys platform should complement growth.
Summit (SMMT) Rides on Upbeat Lung Cancer Study Data
The Zacks Analyst is encouraged by Summit's late-stage data which show that treatment with its experimental cancer drug bested Merck's blockbuster drug Keytruda in certain lung cancer patients.
Loan Growth Support Webster Financial Amid Rising Expenses
Per Zacks analyst, Webster Financial's organic strength is reflected by rising loans and deposits balances. Yet, elevated non-interest expenses remain a concern.
Glaukos' (GKOS) Strong Glaucoma Franchise Offset Competition
Per the Zacks analyst, Glaukos' key franchise, Glaucoma, along with Corneal Health continue on their growth trend due to strong demand which is likely help the company fight off stiff competition.
New Upgrades
Pilgrim's Pride (PPC) Progresses With Strategic Growth Plans
Per the Zacks analyst, Pilgrim's Pride is making strong progress in operational efficiency, Prepared Foods expansion, and cost management, driving higher margins and improved profitability.
Solid Subscription & Political Ad Revenues Aid TEGNA (TGNA)
Per the Zacks analyst, TEGNA is benefiting from continued spike in subscription revenues and strong spending on political advertisements.
New Downgrades
Higher Costs, Weak Production Ail Barrick (GOLD)
Per the Zacks analyst, higher costs will exert pressure on the company's margins. Operational issues across certain mines will also affect its gold production.
Leveraged Balance Sheet & Rivalry Ails America Movil (AMX)
Per the Zacks analyst, America Movil's faces stiff competition from other telecom giants along with a highly leveraged balance sheet remains a concern.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
Hess Corporation (HES) : Free Stock Analysis Report
Dell Technologies Inc. (DELL) : Free Stock Analysis Report
Agnico Eagle Mines Limited (AEM) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
Summit Therapeutics PLC (SMMT) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Analyst Reports for AbbVie, Lockheed Martin & Dell

The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
HAMILTON BEACH BRANDS HOLDING CO (HBB) is a small-cap growth stock in the Appliance & Tool industry. The rating according to our strategy based on Joel Greenblatt changed from 80% to 90% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Hamilton Beach Brands Holding Company is a holding company that operates through its wholly owned subsidiary, Hamilton Beach Brands, Inc. (HBB). HBB is a designer, marketer, and distributor of a range of branded small electric household and specialty houseware appliances, as well as commercial products for restaurants, fast food chains, bars, and hotels. The Company's owned consumer brands include Hamilton Beach, Proctor Silex, Hamilton Beach Professional, Weston, and TrueAir. Its owned commercial brands include Hamilton Beach Commercial and Proctor Silex Commercial. Hamilton Beach Brands licenses the brands for Wolf Gourmet countertop appliances, CHI premium garment care products, Clorox True HEPA air purifiers, and Brita Hub countertop electric water filtration appliances. Its Hamilton Beach Health subsidiary is focused on expanding its participation in the home medical market. Through HealthBeacon PLC, it specializes in developing connected devices in the medical technology market.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
EARNINGS YIELD:
NEUTRAL
RETURN ON TANGIBLE CAPITAL:
NEUTRAL
FINAL RANKING:
PASS
Detailed Analysis of HAMILTON BEACH BRANDS HOLDING CO
HBB Guru Analysis
HBB Fundamental Analysis
Joel Greenblatt Portfolio
Top Joel Greenblatt Stocks
About Joel Greenblatt: In his 2005 bestseller The Little Book That Beats The Market, hedge fund manager Joel Greenblatt laid out a stunningly simple way to beat the market using two -- and only two -- fundamental variables. The "Magic Formula," as he called it, produced back-tested returns of 30.8 percent per year from 1988 through 2004, more than doubling the S&P 500's 12.4 percent return during that time. Greenblatt also produced exceptional returns as managing partner at Gotham Capital, a New York City-based hedge fund he founded. The firm averaged a remarkable 40 percent annualized return over more than two decades.
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Validea Joel Greenblatt Strategy Daily Upgrade Report - 12/12/2024

For Immediate Release
Chicago, IL – November 7, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Shopify Inc. SHOP, The Sherwin-Williams Co. SHW, Fortinet, Inc. FTNT and Hamilton Beach Brands Holding Co. HBB.
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Spotify, Sherwin-Williams and Fortinet
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Shopify Inc. (SHOP), The Sherwin-Williams Co. (SHW) and Fortinet, Inc. (FTNT), as well as a micro-cap stock Hamilton Beach Brands Holding Co. (HBB). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shopify's shares have outperformed the Zacks Internet - Services industry over the past year (+30.8% vs. +29.4%). The company is benefiting from strong growth in its merchant base. New merchant-friendly tools like Bill Pay, Tax Platform, Collective and the Marketplace Connect app are helping it to win new merchants regularly.
Strong adoption of these solutions holds promise for Shopify's prospects. Integration of Shop Pay Installments into the point-of-sale terminal and general availability of Pro makes it easier for merchants to discover and engage their customers. Expansion of back-office merchant solutions to more countries is also strengthening Shopify's international footprint.
An expanding partner base that includes TikTok, Snap, Pinterest, Criteo, IBM, Cognizant, Amazon and Adayen are expected to expand its merchant base further. However, persistent inflation and cautious consumer spending are headwinds.
(You can read the full research report on Shopify here >>>)
Shares of Sherwin-Williams have outperformed the Zacks Chemical - Specialty industry over the past year (+52.9% vs. -0.8%). The company's acquisition of Valspar fortified its position as a leading global paints and coatings provider by expanding its brand portfolio and customer relationships in North America and enhancing its global finishes business. Its aggressive cost-control measures and restructuring initiatives are resulting in strong cash flow, significant shareholder returns and debt reduction.
However, challenges in the heavy equipment and transportation markets, customer destocking and reduced demand in general industries may hurt revenues. North American demand remains weak in the do-it-yourself (DIY) sector. The disruptions related to hurricanes may also adversely impact its performance.
(You can read the full research report on Sherwin-Williams here >>>)
Fortinet's shares have outperformed the Zacks Internet - Software industry over the past year (+55.5% vs. +45.2%). The company is benefiting from rising demand from large enterprise customers and growth in the company's security subscriptions. The company is also gaining from the robust growth in Fortinet Security Fabric, cloud and Software-defined Wide Area Network (SD-WAN) offerings.
Higher IT spending on cybersecurity is further expected to aid Fortinet in growing faster than the security market. We expect 2024 net sales to rise 9.9% from 2023. The company has a strong balance sheet that bodes well for investors. The focus on enhancing its unified threat management (UTM) portfolio through product development and acquisitions is a tailwind for the company.
However, intensifying competition because of increasing consolidation in the security industry poses concerns. Increased hiring and mergers & acquisitions spending remain overhangs on profit margin.
(You can read the full research report on Fortinet here >>>)
Shares of Hamilton Beach Brands have outperformed the Zacks Household Appliances industry over the past year (+63.2% vs. +4.6%). This microcap company with market capitalization of $283.42 million is set for steady North American growth, driven by increased product placements, brand strength, and a digital-first marketing strategy. Expansion into premium appliances, like air purifiers and plant-based milk makers, now contributes 15% of revenue, boosting high-margin segments.
Hamilton Beach Brands' acquisition of HealthBeacon marks an entry into home healthcare with a subscription model, offering strong growth potential. Digital transformation is a key driver, with 48% of U.S. consumer sales from e-commerce, enhancing brand trust.
Margin gains are supported by product mix optimization and cost controls, while solid working capital and pension adjustments improve cash flow. Additionally, global growth, especially in commercial food service and hospitality, diversifies revenue and strengthens Hamilton Beach's position.
(You can read the full research report on Hamilton Beach Brands here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Free Today: Profiting from The Future’s Brightest Energy Source
The demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.
Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.
Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.
Want the latest recommendations from Zacks Investment Research? Today, you can download 5 Stocks Set to Double. Click to get this free report
The Sherwin-Williams Company (SHW) : Free Stock Analysis Report
Fortinet, Inc. (FTNT) : Free Stock Analysis Report
Shopify Inc. (SHOP) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The Zacks Analyst Blog Highlights Shopify, Sherwin-Williams, Fortinet and Hamilton Beach Brands

Wednesday, November 6, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Shopify Inc. (SHOP), The Sherwin-Williams Co. (SHW) and Fortinet, Inc. (FTNT), as well as a micro-cap stock Hamilton Beach Brands Holding Co. (HBB). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shopify’s shares have outperformed the Zacks Internet - Services industry over the past year (+30.8% vs. +29.4%). The company is benefiting from strong growth in its merchant base. New merchant-friendly tools like Bill Pay, Tax Platform, Collective and the Marketplace Connect app are helping it to win new merchants regularly.
Strong adoption of these solutions holds promise for Shopify’s prospects. Integration of Shop Pay Installments into the point-of-sale terminal and general availability of Pro makes it easier for merchants to discover and engage their customers. Expansion of back-office merchant solutions to more countries is also strengthening Shopify’s international footprint.
An expanding partner base that includes TikTok, Snap, Pinterest, Criteo, IBM, Cognizant, Amazon and Adayen are expected to expand its merchant base further. However, persistent inflation and cautious consumer spending are headwinds.
(You can read the full research report on Shopify here >>>)
Shares of Sherwin-Williams have outperformed the Zacks Chemical - Specialty industry over the past year (+52.9% vs. -0.8%). The company’s acquisition of Valspar fortified its position as a leading global paints and coatings provider by expanding its brand portfolio and customer relationships in North America and enhancing its global finishes business. Its aggressive cost-control measures and restructuring initiatives are resulting in strong cash flow, significant shareholder returns and debt reduction.
However, challenges in the heavy equipment and transportation markets, customer destocking and reduced demand in general industries may hurt revenues. North American demand remains weak in the do-it-yourself (DIY) sector. The disruptions related to hurricanes may also adversely impact its performance.
(You can read the full research report on Sherwin-Williams here >>>)
Fortinet’s shares have outperformed the Zacks Internet - Software industry over the past year (+55.5% vs. +45.2%). The company is benefiting from rising demand from large enterprise customers and growth in the company's security subscriptions. The company is also gaining from the robust growth in Fortinet Security Fabric, cloud and Software-defined Wide Area Network (SD-WAN) offerings.
Higher IT spending on cybersecurity is further expected to aid Fortinet in growing faster than the security market. We expect 2024 net sales to rise 9.9% from 2023. The company has a strong balance sheet that bodes well for investors. The focus on enhancing its unified threat management (UTM) portfolio through product development and acquisitions is a tailwind for the company.
However, intensifying competition because of increasing consolidation in the security industry poses concerns. Increased hiring and mergers & acquisitions spending remain overhangs on profit margin.
(You can read the full research report on Fortinet here >>>)
Shares of Hamilton Beach Brands have outperformed the Zacks Household Appliances industry over the past year (+63.2% vs. +4.6%). This microcap company with market capitalization of $283.42 million is set for steady North American growth, driven by increased product placements, brand strength, and a digital-first marketing strategy. Expansion into premium appliances, like air purifiers and plant-based milk makers, now contributes 15% of revenue, boosting high-margin segments.
Hamilton Beach Brands’ acquisition of HealthBeacon marks an entry into home healthcare with a subscription model, offering strong growth potential. Digital transformation is a key driver, with 48% of U.S. consumer sales from e-commerce, enhancing brand trust.
Margin gains are supported by product mix optimization and cost controls, while solid working capital and pension adjustments improve cash flow. Additionally, global growth, especially in commercial food service and hospitality, diversifies revenue and strengthens Hamilton Beach’s position.
(You can read the full research report on Hamilton Beach Brands here >>>)
Other noteworthy reports we are featuring today include Eni S.p.A. (E), Willis Towers Watson Public Limited Co. (WTW) and Yum China Holdings, Inc. (YUMC).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Product Rollouts & Growing Merchant Base Aid Shopify (SHOP)
Acquisitions and Cost Actions to Aid Sherwin-Williams (SHW)
Fortinet (FTNT) Rides on Product Strength, Marketing Efforts
Featured Reports
Eni's (E) Focus on Renewables and Upstream Discoveries Aids
Eni's diversification into renewables and recent hydrocarbon discoveries should support its long-term growth prospects. However, its significant debt exposure concerns the Zacks analyst.
Willis Towers (WTW) Poised to Gain from Segmental Strength
Per the Zacks analyst, Willis Towers is set to gain from solid customer retention levels, growing new business and geographic diversification across segments. Yet, high costs weighing on margin ails.
Loans & Deposit Growth Aid Webster Financial, High Cost Ail
Per Zacks analyst, Webster Financial's organic strength is reflected by rising loans and deposits balances. Yet, rising expenses remain a concern.
Chemed (CHE) Gains from Improved Metrics, Cost Woes Worry
Per the Zacks analyst, Chemed's VITAS sees improved ADC and admissions due to strong hiring and retaining clinical staff, and the benefits of Covenant buyout. Yet, macroeconomic issues escalate cost.
Abercrombie's (ANF) Sturdy Comps Run to Propel Top-Line
Per the Zacks analyst, Abercrombie boasts impressive comparable sales run. Its progress on strategic initiatives, alongside strength in Abercrombie and Hollister brands should drive sales.
Jazz's (JAZZ) Oncology Drugs Fuel Sales & Diversification
While Jazz's sleep disorder portfolio has exhibited strong demand, the Zacks Analyst is impressed with the company's oncology drugs whose sales diversify the existing marketed portfolio.
Allegiant (ALGT) Rides on Air Travel Demand Amid High Expenses
The Zacks Analyst is impressed with the fact that increased air-travel demand is aiding Allegiant's top-line performance. However, rising operating expenses continue to weigh on the bottom line.
New Upgrades
Unit Expansion & Robust Loyalty Program Aid Yum China (YUMC)
Per the Zacks analyst, expansion initiatives, loyalty program, and long-term growth plans are encouraging. For 2024, the company still expects to open approximately 1,500 to 1,700 net new stores.
Diversified Business Model & Solid Buyouts Aid MasTec (MTZ)
Per the Zacks analyst, MasTec is benefiting from a diversified business model reflecting increasing backlog growth and accretive acquisitions. Also, a favorable project and price mix bode well.
Solid Commercial Business Aids First American Financial (FAF)
Per the Zacks analyst, First American is set to grow on solid commercial business and demand among millennials for first-time home purchases. Expanding valuation and data businesses also drive growth.
New Downgrades
Labor Shortage, Poor Financials Hit Huntington Ingalls (HII)
Per the Zacks analyst, the shipbuilding industry is facing labor shortages that might hurt the stock's performance. Moreover, its deteriorating financial ratios implies its poor financial position
Labor Costs, Poor Financials Hurt Spirit AeroSystems (SPR)
Per the Zacks analyst, labor and supply-chain cost growth on the B787 program as well as forward loss related to these might hurt Spirit AeroSystems. It also boasts a weak financial position
Sensing Solutions Slowdown, Rising Expenses Burden Sensata (ST)
Per the Zacks analyst, Sensata's performance is affected by a slowdown in the Sensing solutions segment. Underperforming products' exit and divestiture-related costs led to operating loss.
Zacks Names #1 Semiconductor Stock
It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 5 Stocks Set to Double. Click to get this free report
The Sherwin-Williams Company (SHW) : Free Stock Analysis Report
Eni SpA (E) : Free Stock Analysis Report
Fortinet, Inc. (FTNT) : Free Stock Analysis Report
Willis Towers Watson Public Limited Company (WTW) : Free Stock Analysis Report
Shopify Inc. (SHOP) : Free Stock Analysis Report
Yum China (YUMC) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Research Reports for Shopify, Sherwin-Williams & Fortinet

For Immediate Releases
Chicago, IL – August 26, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Costco Wholesale Corp. COST, Merck & Co., Inc. MRK, Linde plc LIN, Hamilton Beach Brands Holding Co. HBB and Armanino Foods of Distinction, Inc. AMNF.
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Costco, Merck and Linde
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp., Merck & Co., Inc. and Linde plc, as well as two micro-cap stocks Hamilton Beach Brands Holding Co. and Armanino Foods of Distinction, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Costco’s shares have outperformed the Zacks Retail - Discount Stores industry over the year-to-date period (+34.2% vs. +23.2%). This company Being a consumer defensive stock, has been surviving the market turmoil pretty well. The discount retailer’s key strengths are strategic investments, a customer-centric approach, merchandise initiatives, and an emphasis on membership growth.
These factors have been helping it register decent sales and earnings numbers. This outlook reflects Costco’s ability to navigate the challenging operating environment, generate solid sales, and register high membership renewal rates.
A favorable product mix, steady store traffic, pricing power, and strong liquidity position should help Costco keep outperforming. While trading at a premium to its peers, its long-term growth prospects should help the stock see a solid upside.
(You can read the full research report on Costco here >>>)
Shares of Merck have gained +8.0% over the year-to-date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +28.9%. The company is witnessing generic competition for several drugs and rising competitive pressure, mainly on the diabetes franchise, will continue to be overhangs on the top line.
There are concerns about Merck’s ability to grow its non-oncology business ahead of Keytruda’s loss of exclusivity later in the decade. However, Merck beat second-quarter estimates for earnings and sales. Products like Keytruda and Gardasil have been driving sales. With continued label expansion into new indications, particularly earlier-stage launches, Keytruda is expected to see continued growth.
Animal health and vaccine products are core growth drivers. Merck boasts a strong cancer pipeline, including Keytruda, which should drive long-term growth. Merck is investing in M&A activity to strengthen its pipeline.
(You can read the full research report on Merck here >>>)
Linde’s shares have outperformed the Zacks Chemical - Specialty industry over the year-to-date period (+14.6% vs. -17.5%). The company being a global leader in industrial gas manufacturing, supplies a wide range of essential gases to industries such as energy, steel, healthcare, manufacturing and electronics.
The firm secures long-term contracts with key on-site clients that feature minimum purchase agreements. This helps stabilize earnings during economic downturns, supported by its robust business model. Linde reported strong second-quarter earnings, driven by higher pricing from the Americas segment.
However, increasing competition for new projects poses a challenge to the company's return on investment. Additionally, the volatility of energy prices, particularly for natural gas and diesel fuel, presents a significant concern for profitability. An increasing regulatory burden may also negatively impact the industrial gas producer’s overall financial health.
(You can read the full research report on Linde here >>>)
Shares of Hamilton Beach Brands have outperformed the Zacks Household Appliances industry over the year-to-date period (+66.3% vs. -13.8%). This microcap company with market capitalization of $383.56 million reports robust second-quarter 2024 results, driven by a 590-bps year-over-year improvement in the gross profit margin to 25.9%, reflecting effective cost management and strategic pricing.
Revenues grew 14% year over year to $156.2 million, fueled by a strong core market performance in the United States, Mexico and Latin America, and a strategic focus on flagship brands. HBB's financial position strengthened significantly in the second quarter, with net debt reduced to $12.8 million and cash reserves rising to $37.2 million.
Sales in premium markets grew 20%, supported by innovation and strategic licensing. The company’s initiatives and solid global commercial market performance underpin a positive outlook for sustained growth.
(You can read the full research report on Hamilton Beach Brands here >>>)
Armanino Foods of Distinction’s shares have outperformed the Zacks Food - Miscellaneous industry over the year-to-date period (+19.8% vs. +3.0%). This microcap company with market capitalization of $179.57 million delivered record sales and profitability in second-quarter 2024, with a 16% year-over-year increase in net sales to $17.48 million and a 90% surge in pre-tax income, driven by cost efficiencies and margin improvements.
Armanino Foods of Distinction boasts 84 consecutive profitable quarters and a solid balance sheet, with $21.39 million in cash reserves, supporting its growth initiatives. Armanino increased its dividend by 10% and launched a $7-million stock buyback program, highlighting management's confidence.
Strategic geographic expansion, strong market penetration and product diversification, including a 65% market share in food service pesto, enhance its competitive edge. Armanino's commitment to quality, evidenced by its BRC Grade AA certification, underpins its market leadership and positions the company for continued growth.
(You can read the full research report on Armanino Foods of Distinction here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
Linde PLC (LIN) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
Armanino Foods of Distinction Inc. (AMNF): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The Zacks Analyst Blog Costco, Merck & Co., Linde, Hamilton Beach Brands and Armanino Foods of Distinction

Friday, August 23, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp. (COST), Merck & Co., Inc. (MRK) and Linde plc (LIN), as well as two micro-cap stocks Hamilton Beach Brands Holding Co. (HBB) and Armanino Foods of Distinction, Inc. (AMNF). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Costco’s shares have outperformed the Zacks Retail - Discount Stores industry over the year-to-date period (+34.2% vs. +23.2%). This company Being a consumer defensive stock, has been surviving the market turmoil pretty well. The discount retailer’s key strengths are strategic investments, a customer-centric approach, merchandise initiatives, and an emphasis on membership growth.
These factors have been helping it register decent sales and earnings numbers. This outlook reflects Costco’s ability to navigate the challenging operating environment, generate solid sales, and register high membership renewal rates.
A favorable product mix, steady store traffic, pricing power, and strong liquidity position should help Costco keep outperforming. While trading at a premium to its peers, its long-term growth prospects should help the stock see a solid upside.
(You can read the full research report on Costco here >>>)
Shares of Merck have gained +8.0% over the year-to-date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +28.9%. The company is witnessing generic competition for several drugs and rising competitive pressure, mainly on the diabetes franchise, will continue to be overhangs on the top line.
There are concerns about Merck’s ability to grow its non-oncology business ahead of Keytruda’s loss of exclusivity later in the decade. However, Merck beat second-quarter estimates for earnings and sales. Products like Keytruda and Gardasil have been driving sales. With continued label expansion into new indications, particularly earlier-stage launches, Keytruda is expected to see continued growth.
Animal health and vaccine products are core growth drivers. Merck boasts a strong cancer pipeline, including Keytruda, which should drive long-term growth. Merck is investing in M&A activity to strengthen its pipeline.
(You can read the full research report on Merck here >>>)
Linde’s shares have outperformed the Zacks Chemical - Specialty industry over the year-to-date period (+14.6% vs. -17.5%). The company being a global leader in industrial gas manufacturing, supplies a wide range of essential gases to industries such as energy, steel, healthcare, manufacturing and electronics.
The firm secures long-term contracts with key on-site clients that feature minimum purchase agreements. This helps stabilize earnings during economic downturns, supported by its robust business model. Linde reported strong second-quarter earnings, driven by higher pricing from the Americas segment.
However, increasing competition for new projects poses a challenge to the company's return on investment. Additionally, the volatility of energy prices, particularly for natural gas and diesel fuel, presents a significant concern for profitability. An increasing regulatory burden may also negatively impact the industrial gas producer’s overall financial health.
(You can read the full research report on Linde here >>>)
Shares of Hamilton Beach Brands have outperformed the Zacks Household Appliances industry over the year-to-date period (+66.3% vs. -13.8%). This microcap company with market capitalization of $383.56 million reports robust second-quarter 2024 results, driven by a 590-bps year-over-year improvement in the gross profit margin to 25.9%, reflecting effective cost management and strategic pricing.
Revenues grew 14% year over year to $156.2 million, fueled by a strong core market performance in the United States, Mexico and Latin America, and a strategic focus on flagship brands. HBB's financial position strengthened significantly in the second quarter, with net debt reduced to $12.8 million and cash reserves rising to $37.2 million.
Sales in premium markets grew 20%, supported by innovation and strategic licensing. The company’s initiatives and solid global commercial market performance underpin a positive outlook for sustained growth.
(You can read the full research report on Hamilton Beach Brands here >>>)
Armanino Foods of Distinction’s shares have outperformed the Zacks Food - Miscellaneous industry over the year-to-date period (+19.8% vs. +3.0%). This microcap company with market capitalization of $179.57 million delivered record sales and profitability in second-quarter 2024, with a 16% year-over-year increase in net sales to $17.48 million and a 90% surge in pre-tax income, driven by cost efficiencies and margin improvements.
Armanino Foods of Distinction boasts 84 consecutive profitable quarters and a solid balance sheet, with $21.39 million in cash reserves, supporting its growth initiatives. Armanino increased its dividend by 10% and launched a $7-million stock buyback program, highlighting management's confidence.
Strategic geographic expansion, strong market penetration and product diversification, including a 65% market share in food service pesto, enhance its competitive edge. Armanino's commitment to quality, evidenced by its BRC Grade AA certification, underpins its market leadership and positions the company for continued growth.
(You can read the full research report on Armanino Foods of Distinction here >>>)
Other noteworthy reports we are featuring today include Chipotle Mexican Grill, Inc. (CMG), Truist Financial Corp. (TFC) and M&T Bank Corp. (MTB).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Decent Comparable Sales Run to Fuel Costco's (COST) Top Line
Keytruda to Remain Merck's (MRK) Key Top-Line Driver
Linde's (LIN) Long-Term Contracts With Minimum Volume Aid
Featured Reports
Chipotle (CMG) Banks on Digital Initiatives, High Costs Ail
Per the Zacks analyst, Chipotle's consistent strength in digital sales, rise in menu prices and new restaurant openings bode well. However, elevated labor expense is a concern.
High Rates, Fee Income Aid Truist Financial (TFC), Costs Ail
Per the Zacks analyst, Truist Financial's efforts to improve fee income and the current high-rate environment will aid the top line. Elevated costs due to investments in technology will hurt profits.
Loan Growth Supports M&T Bank (MTB), Rising Costs a Woe
Per the Zacks analyst, M&T Bank's top line gets support from increasing loans and deposits balances. However, an escalating expense base keep bottom line under pressure.
Cost Management & Regulated investment Aid Exelon (EXC)
Per the Zacks analyst Exelon's cost management initiatives will have positive impact on margins and its planned $34.5B investments through 2027 will strengthen its operation.
Strong Momentum Across Segments Aids HubSpot's (HUBS) Revenues
Per the Zacks Analyst, strong user engagement across all segments is boosting HubSpot's (HUBS) top line. Integration of AI across its product suite further aids the company.
Expanding Clientele, Hybrid-Working Solutions Aids Zoom (ZM)
Per the Zacks analyst, Zoom is benefiting from solid adoption of hybrid-working solutions like Zoom Phone and expanding subscriber base driven by the need for digital transformation among enterprises.
Improving User Engagement, Partnerships to Drive Snap (SNAP)
Per the Zacks analyst, extended partnerships with the likes of Comcast and Viacom related to new content production are expected to boost Snap's audience base as well as user engagement.
New Upgrades
Strong Demand, Price Hikes Aid Packaging Corporation (PKG)
Per the Zacks analyst, Packaging Corp will gain on robust packaging demand backed by e-commerce and rising requirement for packaging of food, beverages and medicines as well as its pricing actions.
Universal Health (UHS) Rides on Solid Acute Care Platform
Per the Zacks Analyst, growing patient admissions and expansion initiatives in the Acute Care Hospital Services unit drive revenue growth. An adequate cash balance ensures business investments.
Rising Orders at Architectural Services to Aid Apogee (APOG)
Per the Zacks analyst, a solid backlog and a strong project pipeline in its Architectural Services segment will drive Apogee's performance. Focus on improving efficiency will aid margins.
New Downgrades
Copa Holdings' (CPA) Prospects Hurt by High Operating Costs
High fuel and labor expenses at Copa Holdings bother the Zacks analyst. Weakness pertaining to passenger yield and cargo revenues represents another headwind.
Excess Inventory & Declining Order Backlog Ail Winnebago (WGO)
Per the Zacks analyst, the presence of excess inventory in the motorhome RV and marine categories poses challenges to Winnebago. The declining backlog in motorized RV & towable RV is also concerning.
Destocking and FX Headwind To Ail West Pharmaceutical (WST)
Per the Zacks analyst, higher customer destocking across West Pharmaceutical's business units is likely to continue in upcoming quarters, hurting sales. FX headwind to hurt 2024 revenues by $5 million
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.0% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merck & Co., Inc. (MRK) : Free Stock Analysis Report
Chipotle Mexican Grill, Inc. (CMG) : Free Stock Analysis Report
M&T Bank Corporation (MTB) : Free Stock Analysis Report
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
Linde PLC (LIN) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
Armanino Foods of Distinction Inc. (AMNF): Free Stock Analysis Report
Truist Financial Corporation (TFC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Top Analyst Reports for Costco, Merck & Linde

For Immediate Releases
Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Applied Materials, Inc. AMAT, Comcast Corp. CMCSA, Synopsys, Inc. SNPS and Hamilton Beach Brands Holding Co. HBB.
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Applied Materials, Comcast, Synopsys & More
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc., Comcast Corp., and Synopsys, Inc., as well a micro-cap stock Hamilton Beach Brands Holding Co. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Applied Materials shares have outperformed the Zacks Semiconductor Equipment - Wafer Fabrication industry over the year-to-date period (+50.1% vs. +43.3%). The company is benefiting from strength in the Applied Global Services segment, owing to the growing adoption of the 200-mm system, strong recurring services and rising parts sales. Solid momentum in the subscription and display businesses is a plus.
AMAT remains optimistic about its strategies and investments in IoT and AI. Its strength in IoT, Communications, Auto, Power and Sensors (ICAPS) is likely to continue aiding its position in the semiconductor industry in the days ahead. Its broad-based diversified portfolio remains its key growth driver.
However, softness in the Semiconductor Systems segment is a concern. Weakening momentum across Taiwan, Korea, the United States and Europe is a negative. The sluggish demand environment and geo-political tensions are headwinds.
(You can read the full research report on Applied Materials here >>>)
Shares of Comcast have declined -13.3% over the year-to-date period against the Zacks Cable Television industry’s decline of -16.7%, signficantly lagging the S&P 500 index's +16.6% gain over the same time period. Weighing on the stock is the 'cloudy' outlook for the media space in the post-streaming environment and persistent 'cord cutting' in the cable business.
On a favorable note, the company is benefiting from growing domestic wireless subscribers in the first quarter. The company’s plan to transition to DOCSIS 4.0 is noteworthy. The technology will expand it much faster and at a lower cost compared with its competitors.
Decreasing programming and production costs bode well for Comcast's profitability. Its streaming service, Peacock, is a key catalyst in driving broadband sales. Recovery in the theme park and movie business bodes well for the company’s profitability. Strong free cash flow generation ability is noteworthy.
Comcast persistently suffers from video-subscriber attrition due to cord-cutting. The broadband user base declined in the reported quarter due to rising competition from fixed wireless as well as fiber. A leveraged balance sheet is a major concern.
(You can read the full research report on Comcast here >>>)
Synopsys’ shares have outperformed the Zacks Computer - Software industry over the past year (+40.8% vs. +31.5%). The company is benefiting from solid design wins due to a robust product portfolio. Growth in the hybrid working trend is driving demand for bandwidth. Strong traction for Synopsys’ Fusion Compiler product is boosting its top line.
The growing demand for advanced technology, design, IP and security solutions is also creating solid prospects. The rising impact of artificial intelligence, 5G, the Internet of Things and big data is driving investments in new compute and machine learning architectures.
However, tightening the corporate budget amid ongoing macroeconomic challenges, along with unfavorable currency exchange rates and stiff competition, might hurt its near-term growth prospects. Geopolitical challenges and restrictions over trade with Huawei are other woes.
(You can read the full research report on Synopsys here >>>)
Shares of Hamilton Beach Brands have outperformed the Zacks Household Appliances industry over the past year (+77.1% vs. -29.4%). This microcap company with market capitalization of $239.21 million has diversified its product portfolio with a focus on innovation and energy efficiency, marketing well-known brands and expanding into health technology.
Financially, HBB has improved its position by reducing debt from $79.3 million to $50 million. The gross profit margin rose significantly to 23.4% in first-quarter 2024, driven by cost efficiencies and favorable product mixes. HBB's recent dividend increase to 11.5 cents per share demonstrates its commitment to shareholder value.
However, revenue growth remained unchanged year over year due to pricing pressures and competitive markets. Supply-chain risks, supplier concentration in China and a centralized distribution strategy expose HBB to operational disruptions. Selling and administrative expenses have risen primarily due to new ventures and higher employee costs.
(You can read the full research report on Hamilton Beach Brands here >>>)
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Comcast Corporation (CMCSA) : Free Stock Analysis Report
Applied Materials, Inc. (AMAT) : Free Stock Analysis Report
Synopsys, Inc. (SNPS) : Free Stock Analysis Report
Hamilton Beach Brands Holding Company (HBB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	11.42 18.21
Price/Sales	0.48 0.65
P/B	1.95 1.75
P/FCF	5.96 14.40

Indicator	TTM Median
ROE	18.37 15.91
ROA	7.05 5.60
ROI	27.55 9.40
Net Worth	0.31 0.88
Quick Ratio	0.66 0.91
Current Ratio	1.43 1.44

Indicator	TTM Median
Net Profit Margin	4.17 6.42
Operating Margin	6.94 8.93
Gross Margin	26.08 38.46
Return on tangible equity	19.49 23.67

Indicator	TTM Median
EPS	0.14 0.44
EPS Forecast	0.16 0.42
Revenue	157.00M 182.00M
Gross Profit	44.00M —
EBITDA	12.00M —

Hamilton Beach Brands Holding Company

Fundamental HBB

Valuation

Debts

Efficiency

Other ratios

Revenue